pcos presentation

41
Markers and Interventions for Nonobese Women with Polycystic Ovarian Syndrome Zoë Wasserman

Upload: zoe-wasserman

Post on 19-Jan-2017

41 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PCOS Presentation

Markers and Interventions for Nonobese Women with Polycystic

Ovarian SyndromeZoë Wasserman

Page 2: PCOS Presentation

What is Polycystic Ovarian Syndrome?

Page 3: PCOS Presentation

What is Polycystic Ovarian Syndrome?

Polycystic Ovaries Hyperandrogenism

Infrequent/Absent menses

Page 4: PCOS Presentation

What is Polycystic Ovarian Syndrome?

Polycystic Ovaries Hyperandrogenism

Infrequent/Absent menses

5-6 Million Reproductive Age American Women

Page 5: PCOS Presentation

What is Polycystic Ovarian Syndrome?

Polycystic Ovaries Hyperandrogenism

Infrequent/Absent menses

5-6 Million Reproductive Age American Women

Exclusionary Diagnosis

Page 6: PCOS Presentation

PCOS = Exclusionary DiagnosisCongenital Adrenal Hyperplasia

Page 7: PCOS Presentation

PCOS = Exclusionary DiagnosisCongenital Adrenal Hyperplasia

Adrenal Tumor

Page 8: PCOS Presentation

PCOS = Exclusionary DiagnosisCongenital Adrenal Hyperplasia

Hypothyroidism:Low Production of Thyroid HormoneAdrenal Tumor

Page 9: PCOS Presentation

PCOS = Exclusionary DiagnosisCongenital Adrenal Hyperplasia

Cushing Syndrome:Excessive Cortisol Production

Hypothyroidism:Low Production of Thyroid HormoneAdrenal Tumor

Page 10: PCOS Presentation

Rotterdam Criteria: Hyperandrogenism>80% cases

Roe & Dokras, (2011).

Page 11: PCOS Presentation

Rotterdam Criteria: Oligo-Anovulation

(Roe & Dokras, 2011).

Page 12: PCOS Presentation

Rotterdam Criteria: Oligo-Anovulation

→ Earliest Clinical Sign

→ ~ 6-8 week cycles

→ 75% cases(Roe & Dokras, 2011).

Page 13: PCOS Presentation

Rotterdam criteria: polycystic ovaries

Page 14: PCOS Presentation

PCOS Phenotypes● Obese vs Nonobese (overweight, normal, lean)● Hyperandrogen + PCO● Hyperandrogen + Anovulation● Anovulation + PCO● Hyperandrogen + PCO + Anovulation

Page 15: PCOS Presentation

Significance● 60% PCOS patients Obese in USA● 90-95% Anovulatory at fertility Clinics ● 3 x rate of miscarriage● 3x endometrial cancer● Cardiovascular DIsease & Diabetes

Lashen, (2010);Sirmans & Pate, (2013);McGowan, (2011).

Page 16: PCOS Presentation

Are the metabolic risk Factors due to PCOS or Obesity?

Page 17: PCOS Presentation

Are the metabolic risk Factors due to PCOS or Obesity?

?

DyslipidemiaInsulin ResistanceDiabetesGestational DiabetesHIgh blood PressureHeart Disease Chronic Inflammation

Page 18: PCOS Presentation

Are the metabolic risk Factors due to PCOS or Obesity?

DyslipidemiaInsulin ResistanceDiabetesGestational DiabetesHIgh blood PressureHeart Disease Chronic Inflammation

RISK IS INDEPENDENTOF OBESITY!

Page 19: PCOS Presentation

Are the metabolic risk Factors due to PCOS or Obesity?

DyslipidemiaInsulin ResistanceDiabetesGestational DiabetesHIgh blood PressureHeart Disease Chronic Inflammation

RISK IS INDEPENDENTOF OBESITY!

WHY???

Page 20: PCOS Presentation

Are the metabolic risk Factors due to PCOS or Obesity?

DyslipidemiaInsulin ResistanceDiabetesGestational DiabetesHIgh blood PressureHeart Disease Chronic Inflammation

RISK IS INDEPENDENTOF OBESITY!

INNATE INSULINRESISTANCE

Page 21: PCOS Presentation

WHAT IS INSULIN RESISTANCE?

Sirmans & Pate, (2014); Johnson, (2014).

Page 22: PCOS Presentation

How does insulin resistance effect PCOS?

Kilic et al,(2010)

Page 23: PCOS Presentation

Polycystic Ovaries: ● No dominant

follicle chosen● Follicles don’t

undergo cell death

Page 24: PCOS Presentation

Treatments studied:

Page 25: PCOS Presentation

MetforminStop Gluconeogenesis:Lower Glucose Levels

Decrease Insulin Production

(Genazzani et al, 2004).

Increase Production of Sex hormone Binding Globulin (SHBG)

Page 26: PCOS Presentation

MetforminStop Gluconeogenesis:Lower Glucose Levels

Decrease Insulin Production

(Genazzani et al, 2004).

Increase Production of Sex hormone Binding Globulin Hyperandrogenism

Ovulation

Page 27: PCOS Presentation

Oral Contraceptives● Great at creating Menstrual cyclicity &

Preventing Pregnancy● Decrease androgens (increase SHBG)● Decrease hirsutism in 80%● Decreased glucose tolerance● Increase chronic inflammation and BMI● Worsen dyslipidemia Morin-Papunen et al., (2003);Elter, Imir, & Durmusoglu, (2002).

Page 28: PCOS Presentation

Oral Contraceptives and Metformin● Reduction in:

○ Hyperandrogenism○ Waist: Hip○ BMI○ Pregnancy

Increases in:

○ Insulin Sensitivity○ SHBG Elter, Imir, & Durmusoglu, (2002)

Page 29: PCOS Presentation

Clomiphene Citrate● Antiestrogenic: normalizes FSH & LH● faster than metformin● Does not Decrease long term morbidity and Mortality risks

○ Ovarian hyperstimulation syndrome, multiple birth pregnancies & Endometrial thinning

○ Pregnancy rate increased 3.5X when used with metformin

Palomba et al., (2005).; Johnson, (2014)

Ovulation

Page 30: PCOS Presentation

Supplements: Inositol

Oner & Muderris, (2013).

Page 31: PCOS Presentation

Supplements: Inositol ● 1200 mg of D-chiro-inositol, ~ 2 months

○ Serum Androgen

○ Triglycerides

○ 86% Ovulated!

● 2-4g, Myo-Inositol

○ Oocyte quality

○ Ovulation

○ Dyslipidemia & Hyperandrogenism Nestler et al, (1999). & Unfer et al, (2012).

Hyperandrogenism Infrequent/Absent menses

Page 32: PCOS Presentation

Supplements: Vitamin D

Oner & Muderris, (2013).

Page 33: PCOS Presentation

Supplements: Vitamin D ● Deficiency common in PCOS Obese &

Nonobese● Insulin resistance is an independent

predictor of Deficiency● Increase [SHBG]

Velija-Ašimi, (2014).

Hyperandrogenism

Page 34: PCOS Presentation

Supplements: Omega-3

Oner & Muderris, (2013).

Page 35: PCOS Presentation

Supplements: Omega-3 1500 mg/day/6 months

● Hirsutism● BMI● LH ● Testosterone● SHBG Oner & Muderris, (2013).

Hyperandrogenism

Page 36: PCOS Presentation

In Vitro Fertilization & MEtformin● Decrease Ovarian Hyperstimulation

Syndrome: ovaries painful & swollen● Increase oocyte quality● Increase Embryo viability

Kumbak & Kahraman, (2009); Lashen, (2010)

Page 37: PCOS Presentation

Laparoscopic Ovarian DrillingBest Predictor Of Success:● BMI● Androgen Levels● Normal & Overweight

○ 81% Ovulation○ 57% pregnancy

*Lower Variables = Higher Success*Li, & Ledger, W.L., (2004)

Page 38: PCOS Presentation

Gestational Diabetes and Metformin

Page 39: PCOS Presentation

Diet & Exercise

McGowan, (2011) ; Parker, (2015).

Page 40: PCOS Presentation

Diet & Exercise

McGowan, (2011) ; Parker, (2015).

LOw carbohydrate Diets:○ HDL-c○ Triglycerides○ Systolic Blood Pressure○ Weight

Exercise○ Insulin○ Glucose○ Weight

Page 41: PCOS Presentation

Public Health Implications● Holistic Approach to health● Direct health Care costs > $4.36 billion (2005).

○ Diagnosis○ Treatment○ comorbidities

● 7 x suicide rates● Diabetes occurs in 40% < 50 years old● Persistence of Obesity

Parker, (2015); Caglar et al, (2013); McGowan, (2010).